Skopos Labs, Inc. Biomarin Pharmaceutical Inc Call Options Transaction History
Skopos Labs, Inc.
- $497 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BMRN
# of Institutions
694Shares Held
187MCall Options Held
1.31MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.2 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$834 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$798 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$649 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $9.82B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...